Your browser doesn't support javascript.
loading
Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury.
Hernandez, Nelia; Bessone, Fernando; Andrade, Raul.
Affiliation
  • Hernandez N; Unidad Académica Gastroenterología, Hospital de Clínicas, Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay. Electronic address: hernandez.nelia@gmail.com.
  • Bessone F; Hospital Provincial del Centenario, Facultad de Ciencias Médicas, Servicio de Gastroenterología y Hepatología, Universidad Nacional de Rosario, Rosario, Argentina.
  • Andrade R; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, España; Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, España.
Ann Hepatol ; 29(5): 101520, 2024.
Article in En | MEDLINE | ID: mdl-38852782

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemical and Drug Induced Liver Injury / Immunotherapy / Neoplasms Limits: Humans Language: En Journal: Ann Hepatol Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Country of publication: Mexico

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemical and Drug Induced Liver Injury / Immunotherapy / Neoplasms Limits: Humans Language: En Journal: Ann Hepatol Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Country of publication: Mexico